Logo image of CRTO

CRITEO SA-SPON ADR (CRTO) Stock Fundamental Analysis

NASDAQ:CRTO - Nasdaq - US2267181046 - ADR - Currency: USD

37.73  -1.08 (-2.78%)

Fundamental Rating

5

Taking everything into account, CRTO scores 5 out of 10 in our fundamental rating. CRTO was compared to 92 industry peers in the Media industry. While CRTO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CRTO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRTO was profitable.
CRTO had a positive operating cash flow in the past year.
In the past 5 years CRTO has always been profitable.
CRTO had a positive operating cash flow in each of the past 5 years.
CRTO Yearly Net Income VS EBIT VS OCF VS FCFCRTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.60%, CRTO is in the better half of the industry, outperforming 79.07% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.65%, CRTO is in the better half of the industry, outperforming 77.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.74%, CRTO belongs to the top of the industry, outperforming 82.56% of the companies in the same industry.
Industry RankSector Rank
ROA 4.6%
ROE 9.65%
ROIC 8.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRTO Yearly ROA, ROE, ROICCRTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 5.21%, CRTO is in the better half of the industry, outperforming 69.77% of the companies in the same industry.
CRTO's Profit Margin has improved in the last couple of years.
CRTO's Operating Margin of 7.52% is in line compared to the rest of the industry. CRTO outperforms 52.33% of its industry peers.
CRTO's Operating Margin has improved in the last couple of years.
CRTO has a Gross Margin (49.25%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CRTO has grown nicely.
Industry RankSector Rank
OM 7.52%
PM (TTM) 5.21%
GM 49.25%
OM growth 3Y4.83%
OM growth 5Y6.66%
PM growth 3Y-1.1%
PM growth 5Y7.55%
GM growth 3Y13.6%
GM growth 5Y6.76%
CRTO Yearly Profit, Operating, Gross MarginsCRTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRTO is still creating some value.
CRTO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRTO Yearly Shares OutstandingCRTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CRTO Yearly Total Debt VS Total AssetsCRTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.65 indicates that CRTO is not a great score, but indicates only limited risk for bankruptcy at the moment.
CRTO has a Altman-Z score of 2.65. This is amongst the best in the industry. CRTO outperforms 82.56% of its industry peers.
The Debt to FCF ratio of CRTO is 0.03, which is an excellent value as it means it would take CRTO, only 0.03 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRTO (0.03) is better than 94.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CRTO is not too dependend on debt financing.
CRTO has a better Debt to Equity ratio (0.00) than 89.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 2.65
ROIC/WACC1.09
WACC8%
CRTO Yearly LT Debt VS Equity VS FCFCRTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

CRTO has a Current Ratio of 1.17. This is a normal value and indicates that CRTO is financially healthy and should not expect problems in meeting its short term obligations.
CRTO has a Current ratio of 1.17. This is in the lower half of the industry: CRTO underperforms 63.95% of its industry peers.
A Quick Ratio of 1.17 indicates that CRTO should not have too much problems paying its short term obligations.
CRTO's Quick ratio of 1.17 is on the low side compared to the rest of the industry. CRTO is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
CRTO Yearly Current Assets VS Current LiabilitesCRTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.34% over the past year.
Measured over the past years, CRTO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.28% on average per year.
CRTO shows a decrease in Revenue. In the last year, the revenue decreased by -0.83%.
CRTO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.09% yearly.
EPS 1Y (TTM)44.34%
EPS 3Y10.74%
EPS 5Y11.28%
EPS Q2Q%15.13%
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y-4.99%
Revenue growth 5Y-3.09%
Sales Q2Q%5.7%

3.2 Future

Based on estimates for the next years, CRTO will show a small growth in Earnings Per Share. The EPS will grow by 6.88% on average per year.
Based on estimates for the next years, CRTO will show a small growth in Revenue. The Revenue will grow by 7.20% on average per year.
EPS Next Y1.54%
EPS Next 2Y4.77%
EPS Next 3Y6.88%
EPS Next 5YN/A
Revenue Next Year5.36%
Revenue Next 2Y6.47%
Revenue Next 3Y7.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRTO Yearly Revenue VS EstimatesCRTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B
CRTO Yearly EPS VS EstimatesCRTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.22, the valuation of CRTO can be described as very reasonable.
Based on the Price/Earnings ratio, CRTO is valued cheaply inside the industry as 82.56% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.98. CRTO is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 8.10, the valuation of CRTO can be described as very reasonable.
CRTO's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRTO is cheaper than 84.88% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, CRTO is valued rather cheaply.
Industry RankSector Rank
PE 8.22
Fwd PE 8.1
CRTO Price Earnings VS Forward Price EarningsCRTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CRTO's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CRTO is valued a bit cheaper than the industry average as 65.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.97
EV/EBITDA 8.24
CRTO Per share dataCRTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CRTO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.35
PEG (5Y)0.73
EPS Next 2Y4.77%
EPS Next 3Y6.88%

0

5. Dividend

5.1 Amount

No dividends for CRTO!.
Industry RankSector Rank
Dividend Yield N/A

CRITEO SA-SPON ADR

NASDAQ:CRTO (3/3/2025, 3:49:52 PM)

37.73

-1.08 (-2.78%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners99.68%
Inst Owner Change-1.76%
Ins Owners2.24%
Ins Owner Change-3.42%
Market Cap2.08B
Analysts80
Price Target58.91 (56.14%)
Short Float %5.08%
Short Ratio6.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.69%
Min EPS beat(2)13.45%
Max EPS beat(2)37.93%
EPS beat(4)4
Avg EPS beat(4)29.81%
Min EPS beat(4)13.45%
Max EPS beat(4)46.22%
EPS beat(8)7
Avg EPS beat(8)27.33%
EPS beat(12)11
Avg EPS beat(12)25.4%
EPS beat(16)15
Avg EPS beat(16)28.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.28%
Max Revenue beat(2)-0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)3.39%
Revenue beat(8)6
Avg Revenue beat(8)13.09%
Revenue beat(12)10
Avg Revenue beat(12)48.67%
Revenue beat(16)14
Avg Revenue beat(16)77.12%
PT rev (1m)11.06%
PT rev (3m)11.22%
EPS NQ rev (1m)-1.03%
EPS NQ rev (3m)-1.38%
EPS NY rev (1m)6.54%
EPS NY rev (3m)5.82%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-0.97%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 8.22
Fwd PE 8.1
P/S 1.07
P/FCF 11.97
P/OCF 8.33
P/B 1.98
P/tB 5.87
EV/EBITDA 8.24
EPS(TTM)4.59
EY12.17%
EPS(NY)4.66
Fwd EY12.35%
FCF(TTM)3.15
FCFY8.36%
OCF(TTM)4.53
OCFY12.01%
SpS35.28
BVpS19.05
TBVpS6.42
PEG (NY)5.35
PEG (5Y)0.73
Profitability
Industry RankSector Rank
ROA 4.6%
ROE 9.65%
ROCE 11.86%
ROIC 8.74%
ROICexc 10.76%
ROICexgc 35.34%
OM 7.52%
PM (TTM) 5.21%
GM 49.25%
FCFM 8.94%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y4.83%
OM growth 5Y6.66%
PM growth 3Y-1.1%
PM growth 5Y7.55%
GM growth 3Y13.6%
GM growth 5Y6.76%
F-Score8
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0
Cap/Depr 91.47%
Cap/Sales 3.91%
Interest Coverage 99.46
Cash Conversion 108.96%
Profit Quality 171.42%
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 2.65
F-Score8
WACC8%
ROIC/WACC1.09
Cap/Depr(3y)101.15%
Cap/Depr(5y)85.42%
Cap/Sales(3y)4.7%
Cap/Sales(5y)3.96%
Profit Quality(3y)756.67%
Profit Quality(5y)511.62%
High Growth Momentum
Growth
EPS 1Y (TTM)44.34%
EPS 3Y10.74%
EPS 5Y11.28%
EPS Q2Q%15.13%
EPS Next Y1.54%
EPS Next 2Y4.77%
EPS Next 3Y6.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y-4.99%
Revenue growth 5Y-3.09%
Sales Q2Q%5.7%
Revenue Next Year5.36%
Revenue Next 2Y6.47%
Revenue Next 3Y7.2%
Revenue Next 5YN/A
EBIT growth 1Y169.95%
EBIT growth 3Y-0.4%
EBIT growth 5Y3.37%
EBIT Next Year211.67%
EBIT Next 3Y45.83%
EBIT Next 5Y33.26%
FCF growth 1Y199.96%
FCF growth 3Y2.77%
FCF growth 5Y7.59%
OCF growth 1Y32.72%
OCF growth 3Y5.33%
OCF growth 5Y2.99%